|
Report ID
|
138194 |
|
Drug Identification Number
|
02378426 |
|
Brand name
|
LOVENOX |
|
Common or Proper name
|
Lovenox |
|
Company Name
|
SANOFI-AVENTIS CANADA INC |
|
Market Status
|
MARKETED |
|
Active Ingredient(s)
|
ENOXAPARIN SODIUM |
|
Strength(s)
|
60MG |
|
Dosage form(s)
|
SOLUTION |
|
Route of administration
|
SUBCUTANEOUS
SUBCUTANEOUS |
|
Packaging size
|
10 |
|
ATC code
|
B01AB |
|
ATC description
|
ANTITHROMBOTIC AGENTS |
|
Reason for shortage
|
Other (Please describe in comments) |
|
Anticipated start date
|
2021-12-20 |
|
Actual start date
|
|
|
Estimated end date
|
2022-01-31 |
|
Actual end date
|
2022-01-13 |
|
Shortage status
|
Resolved |
|
Updated date
|
2022-01-14 |
|
Company comments
|
Transportation delay and overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage. |
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
email: [email protected]
Telephone: 1-800-265-7927 |
